stockrow
Saturday 7 November 2026
Export BCTX’s income statement to Excel — free account
BRIACELL THERAP
BCTX Healthcare Biotechnology
- EPS
- +110.2%
- Free cash flow
- +26.7%
Quarter to July 2026, against a year earlier
4.00
0.73
+22.32%
Follow BCTX
Alert me
| Jul '26 | Jul '25 | Jul '24 | Jul '23 | Jul '22 | Jul '21 | Jul '20 | Jul '19 | Jul '18 | Jul '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.76 | 5.01 | 0.49 | 14.96 | 45.00 | 103.80 | 0.07 | 0.15 | 1.40 | 1.84 |
Net Debt/EBITDA |
0.57 | 0.66 | 0.03 | 0.91 | 2.69 | 8.23 | 0.01 | (0.03) | 0.17 | 0.63 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 72.54% | 49.05% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.47) | 1.19 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.82 | 1.07 | 5.04 | 1.17 | 0.47 | 0.56 | 0.31 | 0.88 | 0.92 | 0.59 |
Capex/Depreciation |
(1.06) | 0.00 | (5.44) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
— | — | — | (25.69) | (15,288.90) | (88.75) | (133.54) | (198.33) | (244.28) | — |
| (212.23%) | (359.23%) | 148.30% | (619.76%) | (141.26%) | (114.78%) | 189.99% | (2,667.58%) | (509.54%) | (329.47%) | |
| (154.34%) | (191.21%) | (29.01%) | (58.22%) | (53.35%) | (47.18%) | (860.95%) | (317.98%) | (219.39%) | (205.57%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (754.89%) | 0.00% |
Return on Tangible Assets |
(242.68%) | (161.97%) | 140.14% | (80.73%) | (64.82%) | (24.14%) | 108.70% | 488.44% | (772.93%) | (345.31%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.00 | 0.50 | 0.62 | 0.12 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(5.74) | (66.58) | (224.09) | (227.88) | (120.86) | (257.48) | (263.73) | (995.93) | (1,365.49) | (635.84) |
Cash per Share |
4.10 | 42.23 | 7.86 | 203.95 | 397.31 | 1,902.61 | 4.42 | 37.70 | 627.71 | 670.55 |
Shareholders Equity per Share |
3.11 | 40.97 | (24.47) | (36.25) | 99.99 | 919.33 | (749.46) | (165.41) | 339.08 | 311.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.11 | 40.97 | (24.47) | (36.25) | 99.99 | 919.33 | (749.46) | (165.41) | 339.08 | 311.25 |
Free Cash Flow |
(28.78) | (28.17) | (24.58) | (23.74) | (12.48) | (7.75) | (1.27) | (3.85) | (3.89) | (1.44) |
Working Capital |
14.06 | 15.95 | (3.81) | 25.15 | 41.41 | 57.24 | (3.70) | (0.90) | 0.55 | 0.70 |
Capital Expenditures |
(0.13) | — | (0.46) | — | — | — | — | — | — | 0.00 |
Net Current Asset Value |
14.02 | 15.61 | (4.90) | (3.99) | 10.10 | 27.43 | (3.86) | (0.90) | 0.55 | 0.70 |
| Other line items | ||||||||||
Quick Ratio |
2.76 | 5.01 | 0.49 | 14.96 | 43.64 | 102.88 | 0.01 | 0.14 | 1.32 | 1.83 |
Depreciation/Fixed assets |
0.37 | 0.36 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(79.72%) | (80.03%) | 1,348.63% | (135.89%) | (24.30%) | (9.12%) | 35.40% | 1,981.82% | (99.75%) | (64.76%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(5.72) | (66.58) | (219.93) | (227.88) | (120.86) | (257.48) | (263.73) | (995.93) | (1,365.49) | (635.84) |
Capex per Share |
(0.03) | 0.00 | (4.16) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.78 | 2.43 | 4.24 | 2.86 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
Average Payables |
5.14 | 5.23 | 4.15 | 0.79 | 0.34 | 1.96 | 2.23 | 0.49 | 0.29 | 0.21 |
Average Assets |
22.61 | 13.76 | 16.52 | 34.87 | 50.31 | 29.28 | 0.47 | 1.38 | 1.94 | 1.18 |
Average Common Equity |
16.45 | 7.32 | (3.23) | 3.28 | 19.00 | 12.04 | (2.12) | 0.16 | 0.83 | 0.74 |
Capex to Sales |
0.00 | — | 0.00 | — | — | — | — | — | — | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026